With the deepening of medical research, the indications and medication regimens of Selpercatinib are also being optimized. In the future, Selpercatinib is expected to become a treatment option for more patients with specific diseases and contribute more to the treatment of diseases. So, what are the instructions, medical insurance, price, efficacy, and side effects of Selpercatinib for Retevmo?

Selpercatinib(Retevmo) Instructions, Medicare, Price

The following is about Selpercatinib(Retevmo) instructions, medical insurance, and price introduction:

Instruction Manual

Selpercatinib is a capsule drug that is mainly used for the treatment of RET fusion-positive non-small cell lung disease, RET mutant medullary thyroid disease, etc. The recommended dosage is adjusted according to body weight and should be swallowed whole, avoiding crushing or chewing. There may be some side effects associated with the medication. Before use, patients should read the instructions carefully and use under the guidance of a doctor.

Medical insurance

At present, Selpercatinib has not been included in the Chinese medical insurance list. This means that when a patient buys the drug in a hospital or pharmacy, it cannot be reimbursed directly through Medicare and needs to bear the full cost of it.

Price

The price of Selpercatinib varies depending on the manufacturer, specifications, and purchase channel. The Laos Lucius version is a 40mg 120-capsule capsule; The Bangladesh Everest version of 40mg 30 capsules.

Selpercatinib is an important therapeutic drug, and it is necessary to fully understand its label information before use, and pay attention to medical insurance and price in order to make reasonable treatment decisions.

Efficacy, side effects, and side effects of Selpercatinib(Retevmo)

The following is about the efficacy and side effects of Selpercatinib(Retevmo):

Efficacy

Selpercatinib is a highly effective therapeutic drug that is primarily used to treat RET fusions or mutation-positive diseases. By inhibiting RET kinase and its downstream signaling pathway, Selpercatinib can effectively inhibit the growth and spread of diseased cells, thereby prolonging the survival and improving the quality of life of patients.

Side effects

Although Selpercatinib excels in the treatment of the disease, it can also trigger some side effects. Common side effects include edema, diarrhea, high blood pressure, etc., which are usually mild and manageable. There may also be some serious side effects, such as hepatotoxicity, QT interval prolongation, etc., which may pose a greater health threat to patients.

When using Selpercatinib, patients need to pay close attention to their body reactions, and regularly monitor liver function, lung condition, etc., to ensure that possible side effects are detected and treated in a timely manner.